» Articles » PMID: 2410274

Monoclonal Antibodies to Torpedo Acetylcholine Receptor. Characterisation of Antigenic Determinants Within the Cholinergic Binding Site

Overview
Journal Eur J Biochem
Specialty Biochemistry
Date 1985 Aug 1
PMID 2410274
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Thirteen monoclonal antibodies (mAb) to the acetylcholine receptor (AChR) from Torpedo marmorata showed high avidity for the receptor but none exhibited binding to muscle AChR solubilised from seven other animal species. Five mAb and Fab monomer fragments prepared from two of them, inhibited alpha-bungarotoxin (alpha BuTx) binding to receptor by a maximum of 50%. In the presence of excess mAb the 125I-alpha BuTx bound could be precipitated by anti-IgG indicating that the mAb bound to only one of the two alpha BuTx binding sites on each AChR monomer. This site appeared to have a lower affinity for d-tubocurarine and decamethonium than the non-mAb site. Binding of five anti-site mAb was mutually competitive and four of them (AS2-AS5) were inhibited by other cholinergic ligands and influenced by four non-toxin binding site antibodies. One (AS1) bound within the toxin binding site yet outside the main neurotransmitter binding region. It is concluded that these five mAb distinguish between the two alpha BuTx binding sites on the Torpedo AChR, and bind only to the site which displays lower affinity for d-tubocurarine and other competitive ligands.

Citing Articles

Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology.

Fichtner M, Jiang R, Bourke A, Nowak R, OConnor K Front Immunol. 2020; 11:776.

PMID: 32547535 PMC: 7274207. DOI: 10.3389/fimmu.2020.00776.


Characterization of anti-acetylcholine receptor (AChR) antibodies from mice differing in susceptibility for experimental autoimmune myasthenia gravis (EAMG).

Graus Y, Van Breda Vriesman P, De Baets M Clin Exp Immunol. 1993; 92(3):506-13.

PMID: 8513583 PMC: 1554759. DOI: 10.1111/j.1365-2249.1993.tb03429.x.


Myasthenia gravis: an autoimmune response against the acetylcholine receptor.

Graus Y, De Baets M Immunol Res. 1993; 12(1):78-100.

PMID: 7685805 DOI: 10.1007/BF02918370.


Functional architecture of the nicotinic acetylcholine receptor: a prototype of ligand-gated ion channels.

Devillers-Thiery A, Galzi J, Eisele J, Bertrand S, Bertrand D, Changeux J J Membr Biol. 1993; 136(2):97-112.

PMID: 7508983 DOI: 10.1007/BF02505755.


Immunochemical and pharmacological distinctions between curaremimetic neurotoxin binding sites of central, autonomic, and peripheral origin.

Lukas R Proc Natl Acad Sci U S A. 1986; 83(15):5741-5.

PMID: 3461458 PMC: 386365. DOI: 10.1073/pnas.83.15.5741.